Targeting PI3K by CDK-0620 suppresses neutrophilic inflammation

Targeting PI3K by CDK-0620 suppresses neutrophilic inflammation

碩士 === 長庚大學 === 中醫學系天然藥物 === 107

Bibliographic Details
Main Authors:	Hsin Hui Tseng, 曾馨慧
Other Authors:	T. L. Hwang
Format:	Others
Language:	zh-TW
Published:	2019
Online Access:	http://ndltd.ncl.edu.tw/cgi-bin/gs32/gsweb.cgi/login?o=dnclcdr&s=id=%22107CGU05553008%22.&searchmode=basic

Similar Items

Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: a review
by: Siti Muhamad Nur Husna, et al.
Published: (2018-11-01)

THE INCLINATION OF THE SOFT X-RAY TRANSIENT A0620-00 AND THE MASS OF ITS BLACK HOLE
by: Cantrell, Andrew G., et al.
Published: (2015)

Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
by: Yuxiang Wang, et al.
Published: (2019-03-01)

Targeting PI3K, FGFR, CDK4/6 Signaling Pathways Together With Cytostatics and Radiotherapy in Two Medulloblastoma Cell Lines
by: Monika Lukoseviciute, et al.
Published: (2021-09-01)

Erratum to Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
by: Yuxiang Wang, et al.
Published: (2019-12-01)

Susceptibility to Tuberculosis Is Associated With PI3K-Dependent Increased Mobilization of Neutrophils
by: Gina R. Leisching
Published: (2018-07-01)

Lulin One-meter Telescope Observations for Black Hole Binaries Swift J1753.5-0127 and A0620-00
by: Ching-hsiung Wu, et al.
Published: (2010)

Lactoferrin Suppresses Neutrophil Extracellular Traps Release in Inflammation
by: Koshu Okubo, et al.
Published: (2016-08-01)

Cyclin K goes with Cdk12 and Cdk13
by: Kohoutek Jiri, et al.
Published: (2012-04-01)

Studies on the PI3K-dependency of [beta]2 integrin distribution in mouse neutrophils
by: Da Cruz Margarido, Tânia Carina
Published: (2011)

GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia
by: Cheng Zhou, et al.
Published: (2021-03-01)

Tribunal Supremo de Justicia de Venezuela Sala Constitucional 23 de Marzo de 2004: Exp. N° 04-0620
by: José Manuel Delgado Ocando
Published: (2004-01-01)

miR-142-3p Suppresses Cell Growth by Targeting CDK4 in Colorectal Cancer
by: Xiangyu Zhu, et al.
Published: (2018-12-01)

Targeting Neutrophil Apoptosis for Enhancing the Resolution of Inflammation
by: Driss El Kebir, et al.
Published: (2013-05-01)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
by: Boris V. Chernyak, et al.
Published: (2021-09-01)

Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma
by: Zhong-Kun Xia, et al.
Published: (2021-07-01)

MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway
by: Lv Z, et al.
Published: (2019-10-01)

Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways
by: Hosford SR, et al.
Published: (2014-08-01)

Genetic Deletion and Pharmacological Inhibition of PI3Kγ Reduces Neutrophilic Airway Inflammation and Lung Damage in Mice with Cystic Fibrosis-Like Lung Disease
by: Maria Galluzzo, et al.
Published: (2015-01-01)

The Multifaceted Roles of PI3Kγ in Hypertension, Vascular Biology, and Inflammation
by: Marialuisa Perrotta, et al.
Published: (2016-11-01)

Targeting PI3K in cancer: any good news?
by: Miriam eMartini, et al.
Published: (2013-05-01)

Targeting PI3K Signaling in Acute Lymphoblastic Leukemia
by: Vanessa Edna Sanchez, et al.
Published: (2019-01-01)

Targeting PI3K/mTOR signaling in cancer
Published: (2014)

Extracellular AMP Suppresses Endotoxemia-Induced Inflammation by Alleviating Neutrophil Activation
by: Ye Hua, et al.
Published: (2020-07-01)

6-Gingerol Protects Heart by Suppressing Myocardial Ischemia/Reperfusion Induced Inflammation via the PI3K/Akt-Dependent Mechanism in Rats
by: Tongtong Xu, et al.
Published: (2018-01-01)

Heterophyllin B Ameliorates Lipopolysaccharide-Induced Inflammation and Oxidative Stress in RAW 264.7 Macrophages by Suppressing the PI3K/Akt Pathways
by: Chunjing Yang, et al.
Published: (2018-03-01)

Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer
by: Neil A. O’Brien, et al.
Published: (2020-08-01)

MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction]
by: Lv Z, et al.
Published: (2021-09-01)

Neutrophil serine proteases as triggers of inflammation and as targets of autoimmunity
by: Kessenbrock, Kai
Published: (2009)

Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells
by: Mara Bonelli, et al.
Published: (2020-07-01)

Estrogen improved the regeneration of axons after subcortical axon injury via regulation of PI3K/Akt/CDK5/Tau pathway
by: Xiaohui Xia, et al.
Published: (2020-09-01)

Targeting allosteric site of AKT by 5,7-dimethoxy-1,4-phenanthrenequinone suppresses neutrophilic inflammationResearch in context
by: Po-Jen Chen, et al.
Published: (2019-02-01)

Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
by: Chenhao Tong, et al.
Published: (2021-02-01)

Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT
by: Yaodong Zhang, et al.
Published: (2018-10-01)

Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?
by: Célia Cintas, et al.
Published: (2018-01-01)

The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma
by: Norihiko Saito, et al.
Published: (2019-01-01)

Corrigendum to “6-Gingerol Protects Heart by Suppressing Myocardial Ischemia/Reperfusion Induced Inflammation via the PI3K/Akt-Dependent Mechanism in Rats”
by: Tongtong Xu, et al.
Published: (2019-01-01)

GPR174 suppression attenuates retinopathy in angiotensin II (Ang II)-treated mice by reducing inflammation via PI3K/AKT signaling
by: Jianzhong Yue, et al.
Published: (2020-02-01)

MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6
by: Kegan Zhu, et al.
Published: (2016-05-01)

Beyond EGFR Targeting in SCCHN: Angiogenesis, PI3K, and Other Molecular Targets
by: Esma Saada-Bouzid, et al.
Published: (2019-02-01)

Cannot write session to /tmp/vufind_sessions/sess_iu00aatl37rg0v6o4hk4k72158